Evidence map›Paper›PMID 37417371›Full record

SynthesisClinical cardiology2023

Comparison of drug-coated balloon angioplasty versus common balloon angioplasty for arteriovenous fistula stenosis: A systematic review and meta-analysis.

Yong Zhang, Fan-Li Yuan, Xiang-Yang Hu, Qi-Bing Wang, Zhen-Wu Zou, Zhen-Guo Li

Open access · goldAbstract readMeta-AnalysisSystematic Review
In one paragraph

Synthesis in Clinical cardiology, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
4.7field-weighted citation impact, top 5% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 3 institutions in 1 country.

Yong ZhangDepartment of Nephrology, Jianli People's Hospital, Jingzhou, China.ORCID http://orcid.org/0000-0002-7084-9849
Fan-Li YuanDepartment of Nephrology, The First Affiliated Hospital of Yangtze University, Jingzhou, China.
Xiang-Yang HuDepartment of Emergency, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.
Qi-Bing WangDepartment of Emergency, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.
Zhen-Wu ZouDepartment of General Practice, The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture, Enshi, China.
Zhen-Guo LiDepartment of Pediatrics, Jianli People's Hospital, Jingzhou, China.
The Central Hospital of Enshi Tujia and Miao Autonomous Prefecture · CNJingzhou Central Hospital · CNYangtze University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Drug-coated balloons (DCBs) have been used in dialysis patients with arteriovenous fistula (AVF) stenosis, but whether DCBs have advantages over ordinary balloons is still controversial. A meta-analysis was designed to investigate the safety and efficacy of DCBs and common balloons (CBs) in the treatment of AVF stenosis. We searched the PubMed, EMBASE, and China National Knowledge Internet (CNKI) databases for randomized controlled trials that evaluated the comparison of DCB angioplasty versus CB angioplasty for AVF stenosis in dialysis patients and reported at least one outcome of interest. The results showed that the DCB group had a higher first-stage patency rate of the target lesion 6 months [odds ratio, OR = 2.31, 95% confidence interval, CI: (1.69, 3.15), p < .01] and 12 months [OR = 2.09, 95% CI: (1.50, 2.91), p < .01] after surgery. There was no statistically significant difference in all-cause mortality between the two groups at 6 months [OR = 0.85, 95% CI: (0.47, 1.52), p = .58] and 12 months [OR = 0.99, 95% CI: (0.60, 1.64), p = .97]. Compared with CB, DCBs as a new endovascular treatment for AVF stenosis have a higher primary patency rate of target lesions and can delay the occurrence of restenosis. There is no evidence that DCB can increase the mortality of patients.

Indexed as

Angioplasty, BalloonArteriovenous FistulaCoated Materials, BiocompatibleConstriction, PathologicGraft Occlusion, VascularHumansPaclitaxelTime FactorsTreatment OutcomeVascular PatencyCoated Materials, BiocompatiblePaclitaxelall-cause mortalityarteriovenous fistulacommon balloon angioplastydrug-coated balloonend-stage renal diseasemeta-analysisstenosis

Identifiers

PMID37417371
PMCPMC10436783
OpenAlexW4383483130

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.